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The endogenous circadian pacemaker in mammals is located in
the suprachiasmatic nuclei (SCN) of the hypothalamus. Various
cues can reset circadian rhythm phase, thereby entraining the
internal rhythm to the environmental cycle, and these effects
can be investigated using an in vitro method to measure phase
shifts of the SCN. Although pituitary adenylate cyclase activating peptide (PACAP) is localized in retinal inputs to the SCN, it
has been reported to alter clock phase only during the subjective day (Hannibal et al., 1997), whereas light alters phase only
in the subjective night. In this study we show that PACAP can
reset the clock in the photic pattern during the subjective night

when applied in 10 pM to 1 nM doses. This appears to be
mediated via a glutamatergic mechanism, possibly by potentiation of NMDA currents as is seen at 10–100 pM. Given at
higher doses (.10 nM), PACAP shifts in the subjective day,
apparently via activation of adenylate cyclase and increased
intracellular cAMP. These results indicate dose and phase
specificity of the effects of PACAP, and a new role as a transmitter in the retinohypothalamic tract.

The suprachiasmatic nuclei (SC N) is an endogenous circadian
pacemaker in mammals (K lein et al., 1991). Under constant
conditions, an animal displays a free-running rhythm of ;24 hr,
as determined by its internal clock. Various external cues can
reset circadian rhythm phase, thereby entraining the internal
rhythm to the environmental cycle. Light causes a phase response
pattern mimicked by various chemical and electrical treatments,
such as glutamatergic agents and optic nerve electrical stimulation (Ebling, 1996; Kornhauser et al., 1996; Meijer et al., 1996;
Moore, 1997). Another pattern of phase shifting involves advances during the subjective day and small delays or no shifts
during the subjective night. Inputs that shift in this manner
include access to a novel running wheel, application of neuropeptide Y or serotonergic agonists, and cAM P activators (Mrosovsky, 1995; Miller et al., 1996).
Photic information is relayed to the SC N via the retinohypothalamic tract (Ebling, 1996; Kornhauser et al., 1996; Meijer et al.,
1996; Moore, 1997). Neurochemicals associated with the retinohypothalamic tract include glutamate acting at both NMDA and
non-NMDA receptors, and the peptides substance P and pituitary
adenylate cyclase activating peptide (PACAP) (Ebling, 1996;
Hannibal et al., 1997, 1998; Moore, 1997).
A member of the vasoactive intestinal polypeptide (VIP)/
glucagon /secretin /growth-hormone-releasing hormone super-

family, PACAP can either activate cAMP signal cascades via
stimulation of adenylate cyclase or alter inositol phosphate levels
via phospholipase C (Masuo et al., 1993; Spengler et al., 1993;
Arimura and Said, 1996). Both forms of PACAP (PACAP-38 and
PACAP-27) are widely distributed (Masuo et al., 1993; Arimura
et al., 1996). PACAP regulates hormone release from the pituitary, pancreas, and adrenal gland, and may be involved in spermatogenesis and neuritogenesis (Arimura et al., 1996). Two
subclasses of PACAP receptors exist in the SCN, type I and type
II (Hannibal et al., 1997). The type I receptor has high affinity for
PACAP and low affinity for VIP, whereas the type II receptor has
similar affinities for PACAP and VIP (Spengler et al., 1993;
Arimura et al., 1996).
Although the presence of PACAP in the retinohypothalamic
tract suggests a role in conveying photic information to the
circadian pacemaker, the action of PACAP to increase cAMP
suggests a role in mediating nonphotic phase shifts during the
subjective day. One study using the in vitro rat SCN preparation
demonstrated that PACAP advances the phase of the firing rate
rhythm during the subjective day, an effect that can be blocked by
previous treatment with the cAMP antagonist Rp-cAMPs (Hannibal et al., 1997). Similarly, we found that PACAP can phase
advance the hamster in vitro SCN firing rate rhythm when applied
in the subjective day (Harrington and Hoque, 1997). On the other
hand, a recent report indicates that PACAP induces increases in
[Ca 21]i independent of cAMP (Kopp et al., 1999). Here we
report results of further studies using the hamster brain slice
preparation to measure phase shifts induced by PACAP.
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MATERIALS AND METHODS
Brain slice studies. Male golden hamsters (.1 mo of age; Charles River
Laboratories, K ingston, N Y) were housed under a 14/10 light /dark cycle,
and animal care was in accordance with Smith College institutional
guidelines. Brain slices were prepared between Z eitgeber time (Z T)
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0 –10, with Z T 12 arbitrarily defined as the time of lights off. Hamsters
were administered an overdose of halothane, and the brain was quickly
dissected. A mechanical tissue chopper was used to prepare coronal
hypothalamic slices (500-mm-thick). Slices were placed into a gas:fluid
interface chamber. Tissue was maintained at the interface between
artificial C SF (AC SF) and warm, humidified 95% O2 and 5% C O2.
AC SF containing (mM): 125.2 NaC l, 3.8 KC l, 1.2 K H2PO4 , 1.8 C aC l2 ,
1.0 MgSO4 , 24.8 NaHC O3 , and 10 glucose, pH 7.4, was supplemented
with an antibiotic (gentamicin, 50 mg / l) and a f ungicide (amphotericin,
2 mg / l) and maintained at 34.5°C. In some cases we simultaneously
recorded from two SC N slices taken from one hamster. In these cases,
the two slices were given different drug applications, so that the data in
any one experimental group always represents results from slices from
different individuals. Both PACAP-38 and Rp-cAM PS (adenosine 39,59cyclic monophosphothioate, Rp-isomer) were supplied by Sigma (St.
L ouis, MO). AP-5 [(6)-2-amino-5-phosphonopentanoic acid] was purchased from Research Biochemicals International (Natick, M A). All
drugs were applied as a 200 nl microdrop to the SC N on the first day in
vitro. E xtracellular single-unit activity in the SC N was measured using
glass micropipettes filled with AC SF advanced through the slice with a
hydraulic microdrive. The signal was amplified, filtered, and discriminated, and firing rate was measured using a rate monitor and computer.
The spontaneous firing rate of each cell was measured for 1 min. The
average firing rate of each cell was plotted versus the Z T of recording.
Recordings from individual slices were generally conducted for 6 –7 hr
per day on the second day in vitro. Data were grouped into 1 hr bins and
analyzed by an ANOVA. If the ANOVA indicated significant differences
( p , 0.05) across the bins, data were summarized using a 1 hr running
mean smoother with a 15 min lag, and the time of peak firing rate
calculated as the Z T at the middle of the 1 hr bin with the highest value.
The person recording the firing rate data was blind to the drug treatments of the slice, except in one recording (Rp-cAM PS at Z T 6; n 5 1).
Patch-clamp studies. Pregnant female golden hamsters (Charles River
Laboratories) and pups were housed under a 14/10 light /dark cycle with
animal care in accordance with Smith College institutional guidelines.
SC N neurons were acutely dissociated from brain slices of 5- to 15-d-old
hamster pups using the following protocol. Between Z T 0 and 10, pups
were overdosed with halothane anesthesia and decapitated. Brains were
quickly dissected in ice-cold AC SF; 500 mm hypothalamic slices containing the SC N were prepared and placed in AC SF bubbled with 95% O2
and 5% C O2 at room temperature for 1 hr. The SC Ns were then
caref ully cut out with a razor blade and digested in AC SF containing 1.5
mg /ml protease (type X IV from bacterial Streptomyces griseus; Sigma) at
37°C for 5 min. The tissue was then washed twice in H EPES-buffered
minimum essential medium (M EM; Sigma), and cells were dissociated
by gentle trituration in 200 –300 ml of M EM with a fire-polished Pasteur
pipette. The cell suspension was deposited in drops on poly-D-lysinetreated strips of glass coverslip, and cells were allowed to settle for 15 min
before flooding with M EM. C ells were maintained at room temperature
under a 95% O2 and 5% C O2 atmosphere and remained viable for
recording for 4 –5 hr. Coverslips were positioned in the recording bath,
and small SC N neurons of 5–10 mm diameter (unipolar, bipolar, and
multipolar) were easily identified by their morphology. C ells were superf used with (in mM): 140 NaC l, 2.5 KC l, 3 C aC l2 , 10 H EPES, 3 glucose,
and 0.1 mM tetrodotoxin, pH 7.4 with NaOH. Single-channel currents
were recorded from outside-out membrane patches using standard techniques. Fire-polished, borosilicate glass pipettes (World Precision Instruments), fabricated by a two-stage pull (PB-7 puller; Narishige, Tokyo,
Japan) and filled with a solution containing (in mM): 120 K gluconate, 20
KC l, 5 NaC l, 2 MgC l2 , 1 C aC l2 , 1.1 EGTA, 1 ATP (Na 1 salt), 1 GTP
(Na 1 salt), and 10 H EPES, pH 7.3 with KOH, typically had resistances
of 5–10 MV. Membrane patches were held at 250 to 260 mV and were
exposed to combinations of 20 mM NMDA, 100 nM glycine, and varying
PACAP concentrations by bath (volume, 200 –300 ml) exchange (flow
rate, 3 ml /min). All currents were acquired using an Axoclamp 200A
interfaced to a computer running pC lamp 6.1 software (Axon Instruments, Foster C ity, CA). Data were filtered at 1 kHz with a low-pass
8-pole Bessel filter, sampled at 4 kHz and analyzed using pC lamp 6.1.
The duration of openings for NMDA channels at all integral current
levels was assessed throughout the 1 min exposure, a percentage of time
spent in opening was calculated, and values for exposures with and
without PACAP were compared.
In vivo e xperiments. Male Syrian hamsters, 40- to 60-d-old, were
purchased from Charles River (Margate, Kent, UK) and held in LD14:
10. Between 11 and 12 d after arrival, animals were anesthetized with

sodium pentobarbital (;80 mg / kg, i.p.) and fitted with a 25 gauge
stainless steel guide cannula aimed at the SC N. The cannulae were
stereotaxically placed so that the tip was 2.7 mm dorsal to the SC N and
entered the brain slightly off midline at a 10° angle to avoid damaging the
midsagittal sinus. C annulae were held in place with dental cement, and
three small screws were anchored in the skull. A pin consisting of a 10
mm length of 30 gauge stainless steel wire was inserted into the guide
cannula to prevent blockage. After 14 –15 d of recovery, hamsters were
placed in constant dim red light (mean, 24 lux) provided by safelight
lamps fitted with Kodak (Eastman Kodak, Rochester, N Y) filter OA
152–1491. Pilot tests indicated that exposure to this safe light at circadian
time (C T) 1, 5, 9, 13, 17, and 21 for up to 15 min had no effect on the
free-running rhythm of hamsters held in constant darkness (Biello, 1995).
The onset of wheel-running, designated as C T 12, was used as the phase
reference point when timing cannula injections. The onset was defined as
100 wheel revolutions followed by 100 wheel revolutions within the next
30 min. Phase shifts were determined by calculating a regression line for
the five onsets before the manipulation and extrapolated to the day of the
pulse. The activity onset on the pulse day as well as the following two
onsets were omitted from the regression calculation. A second regression
line was calculated from the third through seventh postpulse onsets and
projected back to the pulse day. The difference between the onsets
projected from the prepulse and from the postpulse regression lines was
taken as the phase shift. Microinjections were performed under a red safe
light fitted with a Kodak OA 152–1491 filter. Pilot tests indicated that
exposure to this light at C T 14 for up to 15 min had no effect on the
free-running rhythm of hamsters held in constant darkness (n 5 5; S.
Biello, unpublished data). PACAP or AC SF were injected through a 1 ml
Hamilton syringe connected by ;10 cm of polyethylene tubing to a 13.1
mm stainless steel injection cannula (30 gauge). During the injections the
animals were restrained by hand. After the pin was removed from the
guide cannula, the injection cannula was inserted, the plunger was depressed over a 30 sec period, and the injector was held in place for a
f urther 30 sec. Solutions were freshly prepared on the day of treatment
and delivered in a volume of 200 nl. Hamsters were allowed at least 10 d
between treatments. At the conclusion of the experiment, injections sites
were verified by an injection of 200 nl of ink. Hamsters were perf used,
and 40 mm sections were cut using a cryostat. Data were only included
from hamsters if the cannula tip was within 400 mm of the SC N, the SC N
showed no apparent gliosis, ink was found to enter the SC N, and no ink
was found in the ventricular system.

RESULTS
Hamster SCN cells express a reliable increase in spontaneous
firing rate for ;1 hr in the midsubjective day (ZT 6.3) in control
experiments. The dose–response relationship for phase shifts in
the time of peak firing after applications of PACAP at ZT 6 is
shown in Figure 1 A. Supporting previous reports (Hannibal et al.,
1997; Harrington and Hoque, 1997), we found phase advance
shifts after treatment with doses of 10 nM to 1 mM. A 1 mM dose
at ZT 14 or ZT 18 did not significantly phase shift the rhythm
(Fig. 1C). Thus, a 1 mM dose of PACAP appears to induce phase
advance shifts in the subjective day and no phase shifts in the
subjective night.
We reexamined the phase-shifting effects of PACAP during the
subjective night. We replicated previous results showing that a 1
mM dose of PACAP at ZT 14 did not phase shift the rhythm
(Hannibal et al., 1997). However, lower doses of PACAP were
able to induce phase delay shifts at ZT 14, early in the subjective
night (Fig. 1 B). The dose–response relationship for PACAP at
ZT 14 indicated maximal phase delays after applications of 1 nM
PACAP. This dose of PACAP also induced a phase advance
when applied at ZT 18 on the first day in vitro, but had no
significant phase-shifting effect at ZT 6 (Fig. 1C). Therefore, a 1
nM dose of PACAP appears to induce phase shifts in the photic
pattern.
Because previous studies indicated that PACAP can potentiate
NMDA currents (Liu and Madsen, 1997, 1998; Wu and Dun,
1997), we tested SCN neurons for a similar effect. Outside-out
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Figure 1. Dose- and phase-dependent effects of PACAP. PACAP was
applied on the first day in vitro on the phase of the rhythm in firing rate
recorded from SCN neurons on the second day. A, Dose –response curve
for PACAP applied at ZT 6, midsubjective day. B, Dose –response curve
for PACAP applied at Z T 14. Phase shifts are measured relative to
control slices, untreated, or given microdrop applications of AC SF at
either ZT 6, 14, or 18, which showed peak firing at Z T 6.3 (6 0.1, n 5 7;
range, 6.0 – 6.7). Each symbol represents the mean 6 SEM phase shift of
n 5 3 slices. C, Comparison of the phase-shifting responses to two doses
of PACAP (1 nM vs 1 mM) at three phases: Z T 6, Z T 14, and Z T 18.
Means 6 SEMs are shown; n 5 3 in all groups.

patches were excised from acutely isolated SC N neurons and held
at membrane potentials of 250 to 260 mV. After exposure to 20
mM NMDA–100 nM glycine in the recording medium, channel
activity was observed in all patches. NMDA-induced activity
typically had conductance of 40 –50 pS and there were few contaminating currents. E xposures of 1 min duration every 2 min
gave consistent levels of activity, and responses were nondesensitizing throughout the duration of the application. Inclusion of
PACAP (10 pM) in the NMDA–glycine solution consistently
resulted in an enhanced level of channel activity throughout the
exposure (Fig. 2 A). The potentiating effects of PACAP were
always f ully reversible, with channel activity returning to control
levels after subsequent exposure to NMDA–glycine alone. The
effects of PACAP on NMDA channel activity were dosedependent (Fig. 2 B). At low concentrations (1–100 pM), the
inclusion of PACAP predominantly resulted in potentiated levels
of channel activity. However, at concentrations above 1 nM,
PACAP either had no effect or significantly inhibited activity
levels (Fig. 2 B). Inhibitory effects of PACAP were also reversible.
By using excised membrane patches, we demonstrate that
PACAP can potentiate NMDA currents in SC N neurons independent of cytoplasmic factors.
To test the hypothesis that PACAP phase delays the clock at
ZT 14 via a glutamatergic mechanism, possibly involving potentiation of NMDA currents, we applied the NMDA receptor
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Figure 2. A, PACAP has a dual, potentiating, and inhibitory effect on
NMDA-induced channel activity in outside-out patch recordings from
SC N neurons. A patch was held at 260 mV and exposed to 20 mM
NMDA–100 nM glycine in the absence and presence of two concentrations of PACAP. a, Sample trace of activity in the presence of NMDA–
glycine alone. b, Trace during exposure to NMDA–glycine and 10 pM
PACAP demonstrating increased activity. c, Trace during exposure of the
same patch to NMDA–glycine and 100 nM PACAP showing the pronounced reduction in Popen. B, Dose-dependent effects of PACAP on
NMDA channel activity. Outside-out patches, held at 250 to 260 mV,
were exposed to 20 mM NMDA–100 nM glycine. Values for the proportion
of time spent in open configurations were assessed for channels in the
absence and presence of varying concentrations of PACAP, and potentiations and inhibitions were calculated as percentages above and below
control activity levels. Symbols indicate means, and error bars indicate
SEMs. Each point is averaged from at least five outside-out patch
recordings.

antagonists MK-801 (50 mM) or AP-5 (100 mM or 1 mM) before
PACAP. Both NMDA receptor antagonists were able to block
PACAP phase delay shifts (1 nM PACAP at ZT 14), and had no
effect when applied alone (Fig. 3B). The AMPA–kainate receptor
antagonist CNQX (10 mM) had no effect on the PACAP phase
delay (1 nM PACAP at ZT 14) and had no phase-shifting effect
when applied alone. When applied in the subjective day, MK-801
(50 mM) or AP-5 (1 mM) had no effect on PACAP-induced phase
advances (10 nM PACAP at ZT 6). On the other hand, treatment
with the cAMP antagonist Rp-cAMPS reduced these daytime
phase advances, similar to results from the previous work using
rats (Hannibal et al., 1997) (Fig. 3A). Antagonizing cAMP with
Rp-cAMPS had no effect on the PACAP-induced phase delays at
ZT 14 (Fig. 3B). These findings support the conclusion that
PACAP phase advances the clock in the subjective day by increas-
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Figure 3. A, PACAP phase advances the clock in the subjective day by
increasing cAMP activation. B, Phase delays the clock in the subjective
night by a glutamatergic mechanism. SC N slices were treated with either
PACAP alone or PACAP applied 5 min after application of either
MK-801 (50 mM), AP-5 (100 mM or 1 mM), C NQX (10 mM), or Rp-cAM Ps
(10 mM). The dose of PACAP was chosen from the dose –response curves
shown in Figure 1 (10 nM PACAP at Z T 6; 1 nM PACAP at Z T 14).
Histograms indicate the mean 6 SEM phase shift of n 5 3 slices, except
two control groups with n 5 2: AP-5 at Z T 6 and Rp-cAM PS at Z T 14.

ing cAM P activation, and phase delays the clock in the subjective
night by a glutamatergic mechanism. Thus, two different mechanisms are mediating the subjective day and subjective night phase
shifts of PACAP.
Cannula microinjections of 1 nM PACAP to the area of the
SCN induced small but significant phase shifts in wheel-running
behavior. This pattern of phase shifting resembled phase shifts to
light with phase delays seen at C T 14 –14.5 and advances observed
at CT 18 –18.5 (Fig. 4). The magnitude of these shifts was less
than those seen in the in vitro slice preparation.

DISCUSSION
The doses associated with a photic effect of PACAP in this study
are in agreement with previous reports. PACAP is an exceptionally potent peptide. PACAP can increase [C a 21]i and stimulate
insulin release from rat pancreatic islets in doses as low as 10 214
to 10 213 M (Yada et al., 1994). In doses as low as 10 212 M PACAP
increases [C a 21]i in dissociated supraoptic neurons and stimulates vasopressin release from supraoptic slices (Shibuya et al.,
1998). The neuroprotective effect of PACAP in cultured rat
cortical neurons shows a bell-shaped dose –response curve with
maximal effects in the picomolar range (Morio et al., 1996).
Although we have not directly measured the amount of PACAP

Figure 4. Administration of PACAP in vivo via a cannula aimed at the
SC N resets the circadian clock in a manner similar to light. Doubleplotted actograms show daily activity of individual hamsters with the
activity of each day plotted below the previous day. Arrowheads indicate
PACAP administration on day 7. A, Sample actogram from a hamster
given PACAP at C T 14. B, Sample actogram from a hamster given
PACAP at C T 18. C, Administration of PACAP at C T 14 produced
significant phase delays (n 5 13; mean phase shift, 20.51 6 0.06 SEM)
when compared with AC SF controls (n 5 13; mean phase shift, 20.07 6
0.9 SEM) on a paired t test ( p , 0.001). PACAP microinjected at CT 18
produced small but significant phase advances (n 5 8; mean, 0.45 6 0.39
SEM) when compared with AC SF controls at C T 18 (n 5 8; mean,
20.05 6 0.78 SEM) on a paired t test ( p , 0.005).

released from hamster retinal terminals after photic stimulation,
it is likely that light would release the lower doses (picomolar to
nanomolar range) of PACAP, because these doses altered phase
in a manner similar to light. Although PACAP in the low nanomolar range (0.5–2 nM) potentiates glycine-mediated NMDA
currents in chick cortical neurons, 10 –1000 nM concentrations of
the peptide have an inhibitory effect on this current (Liu and
Madsen, 1997, 1998; Wu and Dun, 1997; current study). For chick
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cortical neurons, the magnitude of the potentiating effect of
PACAP on NMDA currents depends strongly on the amount of
glycine present, suggesting that PACAP may interact with the
glycine site to produce enhancement of NMDA currents (Liu and
Madsen, 1997, 1998; Wu and Dun, 1997). Thus, the potentiation
of PACAP could be regulated by the amount of coincident glycine
release. Alternatively, although the potentiating effects of
PACAP on NMDA currents have been recorded in excised
outside-out patches (Liu and Madsen, 1997; current study),
membrane-delimited modulation of NMDA currents by other
mechanisms, e.g., G-proteins (Yu et al., 1997) or phosopholipase
activation (Spengler et al., 1993) cannot be ruled out. Of particular interest is work indicating that PACAP potentiates
glutamate-evoked release of arachidonic acid from mouse cortical
neurons via a mechanism that does not appear to involve Gs
proteins, or the cAM P–PK A pathway or the phospholipase
C–PKC pathway (Stella and Magistretti, 1996).
PACAP induced a similar pattern of phase shifts in vivo and in
vitro in this study, whereas magnitude of the shifts varied between
the two preparations. This variation could be caused by a multitude of factors, for example, the lack of feedback inhibition in the
isolated SC N.
PACAP content in the rat SC N and pineal gland exhibits a
significant diurnal rhythm in animals housed under light/dark
cycles which disappears after housing in constant darkness, suggesting an exogenous origin of the rhythm (Fukuhara et al., 1997,
1998). These day –night variations in the SC N and in the pineal
gland support a putative role of this peptide in entrainment to the
daily photoperiod.
The mechanism through which PACAP is able to induce
photic-like phase shifts may be related to potentiation of the
effects of glutamate in the SC N. Indeed, PACAP has been shown
to potentiate glutamate-induced Fos expression in cortical neurons (Martin et al., 1995). Both light and PACAP can induce
phosphorylation of the transcription factor cAM P response
element-binding protein (CREB) in the rat SC N (Kornhauser et
al., 1996; Kopp et al., 1997), although the phase specificity of this
effect of PACAP differs from that of light (von Gall et al., 1998).
Phosphorylated CREB can induce immediate early gene transcription, an event associated with photic phase shifts of the
circadian clock (Kornhauser et al., 1996). PACAP has also been
shown to stimulate the expression of BDN F mRNA in mouse
cortical neurons, an effect blocked by NMDA receptor antagonists (Pellegri et al., 1998).
These results allow insight into the actions of this peptide
associated with the retinohypothalamic tract, indicating that
phase shifts in the photic pattern are observed at nanomolar
doses. Several more general insights are possible. First, the action
of the peptide on the circadian clock differs with dose, in that
lower doses (circa 1 nM) phase shift in the photic pattern, apparently via potentiation of NMDA currents, whereas higher doses
(circa 1 mM) phase shift in a different pattern, presumably via
activation of cAM P. Second, the dose –response relationship for
the photic effects of PACAP has a roughly bell-shaped curve
(Figs. 1 B, 2C), suggesting that studies testing only relatively high
doses of PACAP may miss this response completely (Piggins et
al., 1998). Neuropeptides may vary in the amount released so as
to have different cellular effects. It appears that thorough dose–
response studies conducted at several circadian phases are necessary to understand the action of a drug on a neural system
(Miller, 1993).
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